BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21254020)

  • 21. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
    Ballonoff A; Kavanagh B; McCarter M; Kane M; Pearlman N; Nash R; Shah RJ; Raben D; Schefter TE
    Am J Clin Oncol; 2008 Jun; 31(3):264-70. PubMed ID: 18525306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.
    Kim CW; Kim JH; Yu CS; Shin US; Park JS; Jung KY; Kim TW; Yoon SN; Lim SB; Kim JC
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):156-63. PubMed ID: 20106604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.
    Velenik V; Anderluh F; Oblak I; Strojan P; Zakotnik B
    Croat Med J; 2006 Oct; 47(5):693-700. PubMed ID: 17042060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of preoperative irradiation and chemotherapy with capecitabine in patients with locally advanced rectal carcinoma.
    Lay GC; Caraul B; Dessì M; Orrù S; Murtas R; Deidda MA; Farigu R; Farci D; Maxia L; Casula G; Amichetti M
    J Exp Clin Cancer Res; 2007 Mar; 26(1):61-70. PubMed ID: 17550133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
    Freedman GM; Meropol NJ; Sigurdson ER; Hoffman J; Callahan E; Price R; Cheng J; Cohen S; Lewis N; Watkins-Bruner D; Rogatko A; Konski A
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1389-93. PubMed ID: 17394942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis.
    Kerr SF; Norton S; Glynne-Jones R
    Br J Surg; 2008 Dec; 95(12):1534-40. PubMed ID: 18942057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.
    Zampino MG; Magni E; Leonardi MC; Petazzi E; Santoro L; Luca F; Chiappa A; Petralia G; Trovato C; Fazio N; Orecchia R; Nolè F; de Braud F
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):421-7. PubMed ID: 19211200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma.
    Stojanovic S; Popov I; Radosevic-Jelic L; Micev M; Borojevic N; Nikolic V; Krivokapic Z; Kecmanovic D; Gavrilovic D; Kezic I
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):787-93. PubMed ID: 21188380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: a phase II multi-institutional clinical trial (KROG 11-02).
    Lee JH; Kim JG; Oh ST; Lee MA; Chun HG; Kim DY; Kim TH; Kim SY; Baek JY; Park JW; Oh JH; Park HC; Choi DH; Park YS; Kim HC; Chie EK; Jang HS
    Radiother Oncol; 2014 Jan; 110(1):150-4. PubMed ID: 24411228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
    Krishnan S; Janjan NA; Skibber JM; Rodriguez-Bigas MA; Wolff RA; Das P; Delclos ME; Chang GJ; Hoff PM; Eng C; Brown TD; Crane CH; Feig BW; Morris J; Vadhan-Raj S; Hamilton SR; Lin EH
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):762-71. PubMed ID: 17011451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer.
    Korkolis DP; Boskos CS; Plataniotis GD; Gontikakis E; Karaitianos IJ; Avgerinos K; Katopodi A; Xinopoulos D; Dimitroulopoulos D; Beroukas K; Vassilopoulos PP
    Anticancer Res; 2007; 27(1B):541-5. PubMed ID: 17348439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer.
    Pettersson D; Holm T; Iversen H; Blomqvist L; Glimelius B; Martling A
    Br J Surg; 2012 Apr; 99(4):577-83. PubMed ID: 22241246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis.
    Luna-Pérez P; Rodríguez-Ramírez S; Hernández-Pacheco F; Gutiérrez De La Barrera M; Fernández R; Labastida S
    J Surg Oncol; 2003 Jan; 82(1):3-9. PubMed ID: 12501163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting anastomotic complications following anterior resection in rectal cancer.
    Lyall A; Mc Adam TK; Townend J; Loudon MA
    Colorectal Dis; 2007 Nov; 9(9):801-7. PubMed ID: 17931170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.
    Arnaud JP; Nordlinger B; Bosset JF; Boes GH; Sahmoud T; Schlag PM; Pene F
    Br J Surg; 1997 Mar; 84(3):352-7. PubMed ID: 9117306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).
    Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of rectal cancer with radiotherapy with or without concurrent capecitabine--optimising the timing of surgical resection.
    Dhadda AS; Zaitoun AM; Bessell EM
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):23-31. PubMed ID: 19027272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.